WELL Health Technologies Corp. (TSX:WELL)
Canada flag Canada · Delayed Price · Currency is CAD
4.380
+0.040 (0.92%)
Aug 26, 2026, 4:00 PM EST

WELL Health Technologies Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5181,400919.69776.05569.14302.32
Revenue Growth
35.58%52.24%18.51%36.36%88.25%501.76%
Gross Profit
684.21618.84363.01372.27303.29153.7
Operating Income
93.1393.59-29.8634.5233.081.46
Net Income
3.77-7.3632.610.081.37-44.18
Earnings Per Share
0.01-0.030.130.000.01-0.23
EPS Growth
--37471.96%-94.42%--

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Canadian Patient Services - Primary WMC
333.11279.24191.89119.2177.83-
Canadian Patient Services - Specialized WDC
179.67166.52127.56111.32104.2442.46
WELL Health USA Patient Services - Primary Circle Medical
146.91145.176.396.6269.4-
WELL Health USA Patient Services - Primary WISP
115.95115.03100.9777.8858.18-
WELL Health USA Patient Services - Specialized CRH Medical
302.69293.61234.72249.42202.14132.5
WELL Health USA Patient Services - Specialized-Provider Staffing
209.75214.21123.1355.42--
Saas and Technology Services
93.3286.5772.8773.1860.96-
Healwell
139.28113.56----
Corporate/Eliminations
35.820.6615.916.9414.3915.24
Inter-Segment
-38.42-34.32-23.65-23.93-18.01-17.24
Total
1,5181,400919.69776.05569.14302.32

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
130.64133.76131.6743.4248.9161.92
Total Debt
954.13714.08473.14426.28358.42401.94
Net Cash (Debt)
-823.49-580.32-341.47-382.86-309.51-340.02
Net Cash Growth
------
Net Cash Per Share
-3.24-2.30-1.34-1.62-1.40-1.78

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
127.69121.899.5266.4476.5522.27
Capital Expenditures
-44.86-40.15-26.52-25.38-6.62-52.48
Free Cash Flow
82.8381.74-1741.0569.93-30.21
Free Cash Flow Growth
82.99%---41.30%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.07%44.20%39.47%47.97%53.29%50.84%
Operating Margin
6.13%6.68%-3.25%4.45%5.81%0.48%
Pretax Margin
1.24%0.38%0.98%2.51%3.08%-8.43%
Profit Margin
0.25%-0.53%3.55%0.01%0.24%-14.61%
FCF Margin
5.46%5.84%-1.85%5.29%12.29%-9.99%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
295.83-52.4011335.33477.46-
Forward PE
16.2541.96226.40196.02196.02196.02
P/FCF Ratio
13.5312.40-22.649.35-
PS Ratio
0.740.721.861.201.153.38